Study on How Clinicians Use a Metastatic Breast Cancer Prognostic Tool Understanding Its Acceptability and Practical Use

What this Trial Is About

Researchers are conducting a qualitative observational study to assess how acceptable, appropriate, and feasible a new prognostic tool is for clinicians caring for patients with metastatic breast cancer. This tool aims to help identify patients at high risk of death within the next 30 days, with the goal of improving end-of-life care. The study will use interviews guided by implementation science theory to understand how to best integrate this tool into routine clinical practice. The study involves semi-structured interviews with healthcare providers such as physicians, nurse practitioners, physician assistants, and nurse navigators experienced in metastatic breast cancer care. These interviews will be conducted remotely by experienced qualitative researchers, using a flexible interview guide that evolves based on emerging themes. Data will be audio recorded and analyzed to identify barriers and facilitators to using the prognostic tool. Participants will engage in one interview via phone or secure videoconference, sharing their views and experiences. Researchers will evaluate key factors influencing the use of the tool and the discussion of prognosis between clinicians and patients over a 12-month period. The findings will help design an implementation approach to support the tools adoption and improve patient-centered care for those with metastatic breast cancer.

Evaluation of the Acceptability, Appropriateness, and Feasibility/Usability of a Metastatic Breast-cancer Specific Prognostic Calculator Among Clinicians